BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering
December 11, 2024 23:54 ET
|
BriaCell Therapeutics Corp.
PHILADELPHIA and Vancouver, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
Nutanix Announces Pricing of $750 Million 0.50% Convertible Senior Notes
December 11, 2024 23:45 ET
|
Nutanix, Inc.
SAN JOSE, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Nutanix, Inc. (“Nutanix”) (Nasdaq: NTNX) , a leader in hybrid multicloud computing, today announced the pricing of $750 million aggregate...
HUTCHMED Announces Breakthrough Therapy Designation in China for ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients After Disease Progression on EGFR Inhibitor Therapy
December 11, 2024 23:00 ET
|
HUTCHMED (China) Limited
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the Center for Drug Evaluation...
NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
December 11, 2024 21:37 ET
|
NewAmsterdam Pharma N.V.
NAARDEN, the Netherlands and MIAMI, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...
AmpliTech Group Announces Pricing of $2.2 Million Registered Direct Offering
December 11, 2024 21:21 ET
|
AmpliTech Group, Inc.
AmpliTech Group Announces Pricing of $2.2 Million Registered Direct Offering
Financial Institutions, Inc. Announces Pricing of Common Stock Offering
December 11, 2024 19:58 ET
|
Financial Institutions, Inc.
WARSAW, N.Y., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (Nasdaq: FISI) (the “Company”), parent company of Five Star Bank and Courier Capital, LLC, today announced the pricing of...
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”
December 11, 2024 18:30 ET
|
Metagenomi, Inc.
MGX-001, utilizing a highly specific and efficient MG29-1 nuclease, exhibits no identifiable off-target editing MG29-1 nuclease targeting the albumin safe harbor locus showed no evidence of...
NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q
December 11, 2024 18:30 ET
|
NorthView Acquisition Corp.
New York, NY, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market...
Itron Marks Significant Milestone of 50th Temetra Deployment in Australia
December 11, 2024 18:00 ET
|
Itron, Inc.
Itron's Temetra solution enables Aqwest to manage its existing mechanical meters while enhancing and optimizing operations.
UPDATE -- Deep Dive into Capital Clean Energy Carriers Corp. Webinar
December 11, 2024 17:42 ET
|
Capital Clean Energy Carriers Corp.
NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- In the context of Capital Link’s Deep Dive Series, Mr. Jerry Kalogiratos, CEO of Capital Clean Energy Carriers Corp. (NASDAQ: CCEC), joined Mr. Nils...